OVERVIEW
The market for cell signaling is projected to hit USD 5.11 billion by 2025, rising over the forecast period at a CAGR of 6.11%. Factors such as increasing prevalence of chronic diseases, availability of funding for cell-based research, and developments in cell-based research methods are expected to drive the market in the future.
TABLE OF CONTENT
1 Global Cell Signaling Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Cell Signaling Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Cell Signaling Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Cell Signaling Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Cell Signaling Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Cell Signaling Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Cell Signaling Market – By Product (Market Size – & million/billion)
8.1 Consumables
8.2 Instruments
9 Global Cell Signaling Market – By Type
9.1 Endocrine Signaling
9.2 Paracrine Signaling
9.3 Autocrine Signaling
9.4 Juxtacrine Signaling
9.5 Other
10 Global Cell Signaling Market – By Pathway
10.1 Akt
10.2 AMPK
10.3 ErbB/HER
10.4 Hedgehog (Hh)
10.5 JAK/STAT
10.6 NF-êB
10.7 Notch
10.8 Other
11 Global Cell Signaling Market – By Technology
11.1 Microscopy
11.2 Western Blotting
11.3 Flow Cytometry
11.4 Immunohistochemistry (IHC)
11.5 ELISA
11.6 Mass Spectrometry
11.7 Other
12 Global Cell Signaling Market – By Application
12.1 Research
12.2 Medical
13 Global Cell Signaling Market – By Geography (Market Size – & million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa
14 Global Cell Signaling Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships
15 Global Cell Signaling Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Merck KGaA
15.3 Thermo Fisher Scientific Inc.
15.4 Becton, Dickinson and Company
15.5 Perkinelmer, Inc
15.6 Cell Signaling Technology, Inc.
15.7 Promega Corporation
15.8 Bio-Techne Corporation
15.9 Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
15.10 Bio-Rad Laboratories, Inc.
15.11 Qiagen N.V.
15.12 Company 11 & more
16 Global Cell Signaling Market – Appendix
16.1 Sources
16.2 Abbreviations